Wednesday 23 December 2009

Emcolol




Emcolol may be available in the countries listed below.


Ingredient matches for Emcolol



Bisoprolol

Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Emcolol in the following countries:


  • Ireland

International Drug Name Search

Tuesday 22 December 2009

Macrosil




Macrosil may be available in the countries listed below.


Ingredient matches for Macrosil



Roxithromycin

Roxithromycin is reported as an ingredient of Macrosil in the following countries:


  • Spain

International Drug Name Search

Dopamet Medochemie




Dopamet Medochemie may be available in the countries listed below.


Ingredient matches for Dopamet Medochemie



Methyldopa

Methyldopa is reported as an ingredient of Dopamet Medochemie in the following countries:


  • Hong Kong

International Drug Name Search

Monday 21 December 2009

Bepridil Hydrochloride




Bepridil Hydrochloride may be available in the countries listed below.


Ingredient matches for Bepridil Hydrochloride



Bepridil

Bepridil Hydrochloride (BANM, USAN) is known as Bepridil in the US.

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday 18 December 2009

Dekasoft




Dekasoft may be available in the countries listed below.


Ingredient matches for Dekasoft



Ubidecarenone

Ubidecarenone is reported as an ingredient of Dekasoft in the following countries:


  • Japan

International Drug Name Search

Thursday 17 December 2009

Midazolan Biocrom




Midazolan Biocrom may be available in the countries listed below.


Ingredient matches for Midazolan Biocrom



Midazolam

Midazolam is reported as an ingredient of Midazolan Biocrom in the following countries:


  • Argentina

International Drug Name Search

Remitch




Remitch may be available in the countries listed below.


Ingredient matches for Remitch



Nalfurafine

Nalfurafine hydrochloride (a derivative of Nalfurafine) is reported as an ingredient of Remitch in the following countries:


  • Japan

International Drug Name Search

Tuesday 15 December 2009

Anulette




Anulette may be available in the countries listed below.


Ingredient matches for Anulette



Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Anulette in the following countries:


  • Peru

Levonorgestrel

Levonorgestrel is reported as an ingredient of Anulette in the following countries:


  • Peru

International Drug Name Search

Thursday 10 December 2009

Asacol HD


See also: Generic Asacol


Asacol HD is a brand name of mesalamine, approved by the FDA in the following formulation(s):


ASACOL HD (mesalamine - tablet, delayed release; oral)



  • Manufacturer: WARNER CHILCOTT LLC

    Approval date: May 29, 2008

    Strength(s): 800MG [RLD]

Has a generic version of Asacol HD been approved?


No. There is currently no therapeutically equivalent version of Asacol HD available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Asacol HD. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Orally administrable pharmaceutical compositions
    Patent 5,541,170
    Issued: July 30, 1996
    Inventor(s): Rhodes; John & Evans; Brian K.
    Assignee(s): Tillotts Pharma AG
    A solid dosage form, such as a capsule or tablet, containing a pharmacologically active agent is coated with an anionic polymer, which is insoluble in gastric juice and in intestinal juice below pH7 but soluble in colonic intestinal juice, in a sufficient amount that the oral dosage form remains intact until it reaches the colon. The preferred anionic polymer is a partly methyl esterified methacrylic acid polymer in which the ratio of free carboxylic groups to ester groups is about 1:2. The invention has particular application to dosage forms of prednisolone and salts thereof, indomethacin, ibuprofen, and, especially, 5-amino-salicylic acid.
    Patent expiration dates:

    • July 30, 2013
      ✓ 
      Patent use: TREATMENT OF ULCERATIVE COLITIS
      ✓ 
      Drug product




  • Orally administrable pharmaceutical composition
    Patent 5,541,171
    Issued: July 30, 1996
    Inventor(s): Rhodes; John & Evans; Brian K.
    Assignee(s): Tillotts Pharma AG
    A solid dosage form, such as a capsule or tablet, containing a pharmacologically active agent is coated with an anionic polymer, which is insoluble in gastric juice and in intestinal juice below pH7 but soluble in colonic intestinal juice, in a sufficient amount that the oral dosage form remains intact until it reaches the colon. The preferred anionic polymer is a partly methyl esterified methacrylic acid polymer in which the ratio of free carboxylic groups to ester groups is about 1:2. The invention has particular application to dosage forms of prednisolone and salts thereof, indomethacin, ibuprofen, and, especially, 5-amino-salicylic acid.
    Patent expiration dates:

    • July 30, 2013
      ✓ 
      Patent use: TREATMENT OF ULCERATIVE COLITIS
      ✓ 
      Drug product




  • Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
    Patent 6,893,662
    Issued: May 17, 2005
    Inventor(s): Dittmar; Gregory Paul & Amante; Joseph Michael & Cronk; Tony Ryan & Newby; Daniel Gary
    Assignee(s): The Procter & Gamble Company
    The present invention relates to a pharmaceutical composition in a solid unit dosage form for oral administration in a human or lower animal comprising: a. a safe and effective amount of a therapeutically active agent; b. an inner coating layer selected from the group consisting of poly(methacrylic acid, methyl methacrylate) 1:2, poly(methacrylic acid, methyl methacrylate) 1:1, and mixtures thereof; and c. an outer coating layer comprising an enteric polymer or film coating material; wherein the inner coating layer is not the same as the outer coating layer; wherein if the inner coating layer is poly(methacrylic acid, methyl methacrylate) 1:1 then the outer coating layer is not poly(methacrylic acid, methyl methacrylate) 1:2 or is not a mixture of poly(methacrylic acid, methyl methacrylate) 1:1 and poly(methacrylic acid, methyl methacrylate) 1:2; and wherein the inner coating layer and the outer coating layer do not contain any therapeutically active agent. This invention further relates to a method of maintaining the desired site of delivery of a therapeutic agent in the gastrointestinal tract by administering the above compositions to a human or lower animal.
    Patent expiration dates:

    • November 15, 2021
      ✓ 
      Patent use: TREATMENT OF ULCERATIVE COLITIS
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • May 29, 2011 - NEW PRODUCT

See also...

  • Asacol HD Delayed-Release Tablets Consumer Information (Wolters Kluwer)
  • Asacol HD Consumer Information (Cerner Multum)
  • Asacol HD Advanced Consumer Information (Micromedex)
  • Mesalamine Controlled-Release Capsules Consumer Information (Wolters Kluwer)
  • Mesalamine Delayed-Release Tablets Consumer Information (Wolters Kluwer)
  • Mesalamine Enema Consumer Information (Wolters Kluwer)
  • Mesalamine Extended-Release Capsules Consumer Information (Wolters Kluwer)
  • Mesalamine Suppositories Consumer Information (Wolters Kluwer)
  • Mesalamine Consumer Information (Cerner Multum)
  • Mesalamine rectal Consumer Information (Cerner Multum)
  • Mesalamine Advanced Consumer Information (Micromedex)
  • Mesalamine Rectal Advanced Consumer Information (Micromedex)
  • SfRowasa Advanced Consumer Information (Micromedex)
  • Mesalamine AHFS DI Monographs (ASHP)

Wednesday 9 December 2009

Moxylan




Moxylan may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Moxylan



Amoxicillin

Amoxicillin is reported as an ingredient of Moxylan in the following countries:


  • New Zealand

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Moxylan in the following countries:


  • Australia

International Drug Name Search

Tuesday 1 December 2009

Midazolam Hospira




Midazolam Hospira may be available in the countries listed below.


Ingredient matches for Midazolam Hospira



Midazolam

Midazolam hydrochloride (a derivative of Midazolam) is reported as an ingredient of Midazolam Hospira in the following countries:


  • Italy

International Drug Name Search

Friday 27 November 2009

Apo-Tic




Apo-Tic may be available in the countries listed below.


Ingredient matches for Apo-Tic



Ticlopidine

Ticlopidine hydrochloride (a derivative of Ticlopidine) is reported as an ingredient of Apo-Tic in the following countries:


  • Czech Republic

International Drug Name Search

Thursday 26 November 2009

Calcifugo Mediplants




Calcifugo Mediplants may be available in the countries listed below.


Ingredient matches for Calcifugo Mediplants



Salicylic Acid

Salicylic Acid is reported as an ingredient of Calcifugo Mediplants in the following countries:


  • Greece

International Drug Name Search

Wednesday 25 November 2009

Midocin




Midocin may be available in the countries listed below.


Ingredient matches for Midocin



Clindamycin

Clindamycin is reported as an ingredient of Midocin in the following countries:


  • Japan

International Drug Name Search

Tuesday 24 November 2009

Minigeste




Minigeste may be available in the countries listed below.


Ingredient matches for Minigeste



Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Minigeste in the following countries:


  • Portugal

Gestodene

Gestodene is reported as an ingredient of Minigeste in the following countries:


  • Portugal

International Drug Name Search

Sunday 22 November 2009

Garaxil




Garaxil may be available in the countries listed below.


Ingredient matches for Garaxil



Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Garaxil in the following countries:


  • El Salvador

  • Honduras

International Drug Name Search

Thrionipen




Thrionipen may be available in the countries listed below.


Ingredient matches for Thrionipen



Nimodipine

Nimodipine is reported as an ingredient of Thrionipen in the following countries:


  • Greece

International Drug Name Search

Wednesday 18 November 2009

Mabuterol




Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0056341-08-3

Chemical Formula

C13-H18-Cl-F3-N2-O

Molecular Weight

310

Therapeutic Categories

Bronchodilator

ß₂-Sympathomimetic agent

Chemical Names

1-(4'-amino-3'-chloro-5'-trifluoromethylphenyl)-2-tert-butylaminoethanol

4-Amino-3-chloro-α-[[(1,1-dimethylethyl)amino]methyl]-5-(trifluoromethyl)benzenemethanol

4-Amino-α-[(tert-butylamino)methyl]-3-chloro-5-(trifluoromethyl)benzyl alcohol (WHO)

Benzenemethanol, 4-amino-3-chloro-α-[[(1,1-dimethylethyl)amino]methyl]-5-(trifluoromethyl)-

Foreign Names

  • Mabuterolum (Latin)
  • Mabuterol (German)
  • Mabutérol (French)
  • Mabuterol (Spanish)

Generic Names

  • Ambuterol (IS)
  • UNII-R4K19W6S7Q (IS)
  • Mabuterol Hydrochloride (OS: JAN)
  • Ambuterol hydrochloride (IS)
  • KF-868 (IS)
  • PB-868 Cl (IS)

Brand Name

  • Broncholin
    Kaken Seiyaku, Japan

International Drug Name Search

Glossary

ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Metoclopramidum




Metoclopramidum may be available in the countries listed below.


Ingredient matches for Metoclopramidum



Metoclopramide

Metoclopramide hydrochloride (a derivative of Metoclopramide) is reported as an ingredient of Metoclopramidum in the following countries:


  • Poland

International Drug Name Search

Sunday 15 November 2009

Metropolyn




Metropolyn may be available in the countries listed below.


Ingredient matches for Metropolyn



Dipyridamole

Dipyridamole is reported as an ingredient of Metropolyn in the following countries:


  • Japan

International Drug Name Search

Saturday 14 November 2009

Midazolam Hikma




Midazolam Hikma may be available in the countries listed below.


Ingredient matches for Midazolam Hikma



Midazolam

Midazolam hydrochloride (a derivative of Midazolam) is reported as an ingredient of Midazolam Hikma in the following countries:


  • Netherlands

International Drug Name Search

Friday 13 November 2009

Podoxin




Podoxin may be available in the countries listed below.


Ingredient matches for Podoxin



Podophyllotoxin

Podophyllotoxin is reported as an ingredient of Podoxin in the following countries:


  • Argentina

International Drug Name Search

Monday 9 November 2009

Biolorat




Biolorat may be available in the countries listed below.


Ingredient matches for Biolorat



Loratadine

Loratadine is reported as an ingredient of Biolorat in the following countries:


  • Venezuela

International Drug Name Search

Thursday 5 November 2009

Phanerol




Phanerol may be available in the countries listed below.


Ingredient matches for Phanerol



Propranolol

Propranolol hydrochloride (a derivative of Propranolol) is reported as an ingredient of Phanerol in the following countries:


  • Philippines

International Drug Name Search

Saturday 24 October 2009

Enalapril / Hydrochlorthiazid Actavis




Enalapril/Hydrochlorthiazid Actavis may be available in the countries listed below.


Ingredient matches for Enalapril/Hydrochlorthiazid Actavis



Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalapril/Hydrochlorthiazid Actavis in the following countries:


  • Denmark

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Enalapril/Hydrochlorthiazid Actavis in the following countries:


  • Denmark

International Drug Name Search

Friday 23 October 2009

Oxyject




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Oxyject



Oxytetracycline

Oxytetracycline hydrochloride (a derivative of Oxytetracycline) is reported as an ingredient of Oxyject in the following countries:


  • Austria

  • Netherlands

  • United States

International Drug Name Search

Wednesday 21 October 2009

Niamid




Niamid may be available in the countries listed below.


Ingredient matches for Niamid



Nialamide

Nialamide is reported as an ingredient of Niamid in the following countries:


  • Luxembourg

International Drug Name Search

Wednesday 7 October 2009

Meriestra




Meriestra may be available in the countries listed below.


Ingredient matches for Meriestra



Estradiol

Estradiol 17ß-valerate (a derivative of Estradiol) is reported as an ingredient of Meriestra in the following countries:


  • Spain

International Drug Name Search

Cobalatec




Cobalatec may be available in the countries listed below.


Ingredient matches for Cobalatec



Cyanocobalamin

Cyanocobalamin is reported as an ingredient of Cobalatec in the following countries:


  • South Africa

International Drug Name Search

Thursday 1 October 2009

Protonex




Protonex may be available in the countries listed below.


Ingredient matches for Protonex



Pantoprazole

Pantoprazole sodium (a derivative of Pantoprazole) is reported as an ingredient of Protonex in the following countries:


  • Turkey

International Drug Name Search

Wednesday 30 September 2009

Mirtazapina Winthrop




Mirtazapina Winthrop may be available in the countries listed below.


Ingredient matches for Mirtazapina Winthrop



Mirtazapine

Mirtazapine is reported as an ingredient of Mirtazapina Winthrop in the following countries:


  • Italy

  • Portugal

  • Spain

International Drug Name Search

Sunday 27 September 2009

Stellorphinad




Stellorphinad may be available in the countries listed below.


Ingredient matches for Stellorphinad



Morphine

Morphine hydrochloride (a derivative of Morphine) is reported as an ingredient of Stellorphinad in the following countries:


  • Luxembourg

International Drug Name Search

Friday 25 September 2009

Monospirin




Monospirin may be available in the countries listed below.


Ingredient matches for Monospirin



Aspirin

Acetylsalicylic Acid is reported as an ingredient of Monospirin in the following countries:


  • Bangladesh

International Drug Name Search

Wednesday 23 September 2009

Naldix




Naldix may be available in the countries listed below.


Ingredient matches for Naldix



Nalidixic Acid

Nalidixic Acid is reported as an ingredient of Naldix in the following countries:


  • Yemen

International Drug Name Search

Sunday 20 September 2009

Ampicler




Ampicler may be available in the countries listed below.


Ingredient matches for Ampicler



Ampicillin

Ampicillin trihydrate (a derivative of Ampicillin) is reported as an ingredient of Ampicler in the following countries:


  • Argentina

International Drug Name Search

Saturday 19 September 2009

Calcium Vitamine D3 Sandoz




Calcium Vitamine D3 Sandoz may be available in the countries listed below.


Ingredient matches for Calcium Vitamine D3 Sandoz



Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Calcium Vitamine D3 Sandoz in the following countries:


  • France

Colecalciferol

Colecalciferol is reported as an ingredient of Calcium Vitamine D3 Sandoz in the following countries:


  • France

International Drug Name Search

Wednesday 16 September 2009

Methyldopa




In the US, Methyldopa (methyldopa systemic) is a member of the drug class antiadrenergic agents, centrally acting and is used to treat High Blood Pressure and Hypertensive Emergency.

US matches:

  • Methyldopa

  • Methyldopa/Hydrochlorothiazide

  • Methyldopa Oral, Intravenous

  • Methyldopa and hydrochlorothiazide

  • Methyldopa and Methyldopate Hydrochloride

UK matches:

  • Methyldopa Tablets 125mg, 250mg, 500mg (Actavis UK Ltd)

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0000555-30-6

Chemical Formula

C10-H13-N-O4

Molecular Weight

211

Therapeutic Category

Antihypertensive agent

Chemical Name

L-Tyrosine, 3-hydroxy-α-methyl-

Foreign Names

  • Methyldopum (Latin)
  • Methyldopa (German)
  • Méthyldopa (French)
  • Metildopa (Spanish)

Generic Names

  • Méthyldopa (OS: DCF)
  • Metildopa (OS: DCIT)
  • Alpha-methyldopa (IS)
  • Methyldopate Hydrochloride (OS: USAN)
  • Methyldopate hydrochloride (PH: USP 32)
  • Methyldopa (OS: JAN, USAN, BAN)
  • Methyldopum (IS)
  • Methyldopa (PH: BP 2010, JP XIV, Ph. Int. 4, USP 32, Ph. Eur. 6)
  • Méthyldopa (PH: Ph. Eur. 6)
  • Methyldopum (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

  • Aldomet
    Aspen, Australia; Biopat, Spain; Cophana, Belgium; Globopharm, Switzerland; H.A.C. Pharma, France; Merck, Egypt; Merck, Peru; Merck Sharp & Dhome, Oman; Merck Sharp & Dohme, Argentina; Merck Sharp & Dohme, Ethiopia; Merck Sharp & Dohme, Ireland; Merck Sharp & Dohme, Italy; Merck Sharp & Dohme, Luxembourg; Merck Sharp & Dohme, Mexico; Merck Sharp & Dohme, Philippines; Merck Sharp & Dohme, Portugal; Merck Sharp & Dohme, Taiwan; Merck Sharp & Dohme, Venezuela; MSD, Norway; Nippon Universal Pharmaceutical, Japan; Sigma, United Kingdom; Vianex / BIANEΞ, Greece


  • Aldometil
    Merck Sharp & Dohme, Austria


  • Aldomin
    Merck Sharp & Dohme, Israel


  • Aldoril (Methyldopa and Hydrochlorothiazide)
    Merck, United States


  • Alfamet
    I.E. Ulagay, Turkey


  • Alfametildopa
    Spefar, Venezuela


  • Alphadopa
    Wockhardt, India


  • Apo-Methyldopa
    Apotex, Canada; Apotex, Singapore; Apotex, Vietnam


  • Dopagrand
    Ahimsa, Argentina


  • Dopagyt
    Themis, India


  • Dopamet Medochemie
    Medochemie, Hong Kong


  • Dopamet
    Actavis, Indonesia; Dumex, United Arab Emirates; Dumex, Bahrain; Dumex, Cyprus; Dumex, Egypt; Dumex, Ethiopia; Dumex, Iraq; Dumex, Jordan; Dumex, Kuwait; Dumex, Lebanon; Dumex, Libya; Dumex, Qatar; Dumex, Saudi Arabia; Dumex, Sudan; Dumex, Yemen


  • Dopanore
    Saiph, Tunisia


  • Dopatab
    Unifarm, Peru


  • Dopegyt
    Egis, Bulgaria; Egis, Egypt; Egis, Georgia; Egis, Hong Kong; Egis, Hungary; Egis, Sri Lanka; Egis, Lithuania; Egis, Latvia; Egis, Malaysia; Egis, Poland; Egis, Romania; Egis, Russian Federation; Egis, Singapore; Egis, Slovakia; Egis, Syria; Egis, Thailand; Egis, Vietnam; Egis, Yemen; Egis Pharmaceuticals, Ethiopia; Egyt, Ethiopia


  • Fidopa
    Sanofi-Aventis, Bangladesh


  • Halfdopa
    Tatsumi Kagaku, Japan


  • Hydopa
    Alphapharm, Australia


  • Hydromet (Methyldopa and Hydrochlorothiazide)
    Vianex / BIANEΞ, Greece


  • Hypolag
    Lagap Pharma, Ethiopia


  • Hy-Po-Tone
    Aspen Pharmacare, South Africa; Lennon, Ethiopia


  • Medozide (Methyldopa and Hydrochlorothiazide)
    Malesci, Italy


  • Merck-Methyldopa
    Merck Generics, South Africa


  • Methyldopa Alpharma ApS
    Alpharma, Singapore


  • Methyldopa and Hydrochlorothiazide (Methyldopa and Hydrochlorothiazide)
    Mylan, United States; Par, United States; Sandoz, United States; Watson, United States


  • Methyldopa Bidiphar
    Bidiphar, Vietnam


  • Methyldopa CF
    Centrafarm, Netherlands


  • Methyldopa Double-Crane Pharm
    Double-Crane, China


  • methyldopa PCH
    Pharmachemie, Netherlands


  • Methyldopa ratiopharm
    ratiopharm, Netherlands


  • Methyldopa Sandoz
    Sandoz, Netherlands


  • Methyldopa Teriak
    Teriak, Tunisia


  • Methyldopa
    Accord, United States; Actavis, United Kingdom; Hemofarm, Serbia; Johnson, Taiwan; Mylan, United States; Pharmamed, Ethiopia; Remedica, Cyprus; Remedica, Ethiopia; Remedica, Oman; Sandoz, United States; Teva USA, United States; UDL, United States; Watson, United States


  • Metilcord
    Luper, Brazil


  • Metildopa Fabra
    Fabra, Argentina


  • Metildopa L.CH.
    Chile, Chile


  • Metildopa LCH
    Ivax, Peru


  • Metildopa
    Calidad, Venezuela; Srbolek, Serbia


  • Pharmaniaga Methyldopa
    Pharmaniaga, Malaysia


  • Prodopa
    Pacific, New Zealand


  • Sandoz Methyldopa
    Sandoz, South Africa


  • Sardopa
    Incepta, Bangladesh


  • Tensodopa
    Colliere, Peru


  • U pressdopa
    Isei, Japan


  • Methyldopate Hydrochloride
    American Regent, United States; Hospira, United States; Luitpold, United States; Sicor, United States


  • Datleal
    Nipro GenephaNipurojenefa, Japan


  • Dopamide
    Toho Droge, Japan


  • Dopatral
    Austral, Argentina


  • Dopegyt
    Egis, Czech Republic; UCB, Germany


  • Methyldopa Stada
    Stada, Germany


  • Nichidopa
    Nichi-Iko PharmaceuticalJMA, Japan


  • Presinol
    Teofarma, Germany

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Phtharal




Phtharal may be available in the countries listed below.


Ingredient matches for Phtharal



Phthalaldehyde, o-

Phtharal (JAN) is also known as Phthalaldehyde, o-

International Drug Name Search

Glossary

JANJapanese Accepted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday 13 September 2009

Gravynon




Gravynon may be available in the countries listed below.


Ingredient matches for Gravynon



Allylestrenol

Allylestrenol is reported as an ingredient of Gravynon in the following countries:


  • Indonesia

International Drug Name Search

Thursday 10 September 2009

ProAmatine




In the US, ProAmatine (midodrine systemic) is a member of the drug class miscellaneous cardiovascular agents and is used to treat Dysautonomia, Hypotension and Postural Orthostatic Tachycardia Syndrome.

US matches:

  • ProAmatine

Ingredient matches for ProAmatine



Midodrine

Midodrine hydrochloride (a derivative of Midodrine) is reported as an ingredient of ProAmatine in the following countries:


  • United States

International Drug Name Search

Solulexin




Solulexin may be available in the countries listed below.


Ingredient matches for Solulexin



Cefalexin

Cefalexin monohydrate (a derivative of Cefalexin) is reported as an ingredient of Solulexin in the following countries:


  • Hong Kong

International Drug Name Search

Monday 7 September 2009

Gonadotropin Inhibition Medications


Drugs associated with Gonadotropin Inhibition

The following drugs and medications are in some way related to, or used in the treatment of Gonadotropin Inhibition. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:

Sunday 6 September 2009

rilpivirine


ril-pi-VIR-een


Commonly used brand name(s)

In the U.S.


  • Edurant

Available Dosage Forms:


  • Tablet

Therapeutic Class: Antiretroviral Agent


Pharmacologic Class: Non-Nucleoside Reverse Transcriptase Inhibitor


Uses For rilpivirine


Rilpivirine is used together with other medicines to treat human immunodeficiency virus (HIV) infections. HIV is the virus that causes acquired immune deficiency syndrome (AIDS). rilpivirine is usually given to patients who have not received any HIV treatment in the past. Rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It works by lowering the amount of HIV in the blood.


Rilpivirine will not cure HIV infection or AIDS; however, it helps keep HIV from reproducing and appears to slow down the destruction of the immune system. This may help delay the development of problems that usually result from AIDS or HIV disease. Rilpivirine will not keep you from spreading HIV to other people. People who receive rilpivirine may continue to have some of the problems usually related to AIDS or HIV disease.


rilpivirine is available only with your doctor's prescription.


Before Using rilpivirine


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For rilpivirine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to rilpivirine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of rilpivirine in the pediatric population. Safety and efficacy have not been established.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of rilpivirine in the elderly. However, elderly patients are more likely to have age-related kidney or liver problems, which may require caution for patients receiving rilpivirine.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersBAnimal studies have revealed no evidence of harm to the fetus, however, there are no adequate studies in pregnant women OR animal studies have shown an adverse effect, but adequate studies in pregnant women have failed to demonstrate a risk to the fetus.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking rilpivirine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using rilpivirine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Carbamazepine

  • Dexamethasone

  • Esomeprazole

  • Lansoprazole

  • Omeprazole

  • Oxcarbazepine

  • Pantoprazole

  • Phenobarbital

  • Phenytoin

  • Rabeprazole

  • Rifabutin

  • Rifampin

  • Rifapentine

  • St John's Wort

Using rilpivirine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Aluminum Carbonate, Basic

  • Aluminum Hydroxide

  • Aluminum Phosphate

  • Calcium Carbonate

  • Cimetidine

  • Delavirdine

  • Dihydroxyaluminum Aminoacetate

  • Dihydroxyaluminum Sodium Carbonate

  • Efavirenz

  • Etravirine

  • Famotidine

  • Magaldrate

  • Magnesium Carbonate

  • Magnesium Hydroxide

  • Magnesium Oxide

  • Magnesium Trisilicate

  • Nevirapine

  • Nizatidine

  • Ranitidine

Using rilpivirine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Ketoconazole

  • Methadone

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of rilpivirine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Depression, or history of or

  • Heart rhythm problems (eg, QT prolongation) or

  • Liver disease (eg, hepatitis B or C infection)—Use with caution. May make these conditions worse.

  • Kidney disease, severe—Use with caution. The effects may be increased because of slower removal of the medicine from the body.

Proper Use of rilpivirine


Take rilpivirine exactly as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered. Also, do not change the dose or stop using rilpivirine without checking first with your doctor. When your supply of rilpivirine is running low, contact your doctor or pharmacist ahead of time. Do not allow yourself to run out of rilpivirine.


Keep taking rilpivirine for the full time of treatment, even if you begin to feel better.


It is important to take rilpivirine together with other medicines. Take all other medicines your doctor has prescribed at the right time of day. This will make your medicines work better.


It is best to take rilpivirine with food.


rilpivirine comes with a patient information insert. Read and follow these instructions carefully before starting rilpivirine and each time you refill your prescription. Ask your doctor if you have any questions.


If you are taking a stomach medicine for heartburn or ulcers (such as cimetidine, famotidine, nizatidine, ranitidine, Axid®, Pepcid®, Tagamet®, or Zantac®), take the heartburn medicine at least 12 hours before or 4 hours after rilpivirine.


If you are taking antacids that contain aluminum, magnesium, or calcium, take the antacid at least 2 hours before or 4 hours after rilpivirine.


If you are taking didanosine (Videx®), take the medicine on an empty stomach and at least 2 hours before or 4 hours after rilpivirine.


Dosing


The dose of rilpivirine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of rilpivirine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (tablets):
    • For treatment of HIV infection:
      • Adults—25 milligrams (mg) once a day.

      • Children—Use and dose must be determined by your doctor.



Missed Dose


If you miss a dose of rilpivirine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


If you miss a dose or forget to use your medicine and it is less than 12 hours since your last dose, take it as soon as you can and take your next dose at the normal time. If you miss a dose or forget to use it, and it is more than 12 hours since your last dose, wait and take your next dose at the normal time. Do not use extra medicine to make up for a missed dose.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using rilpivirine


It is very important that your doctor check your progress at regular visits to make sure that rilpivirine is working properly. Blood tests may be needed to check for unwanted effects.


Do not use rilpivirine if you are also taking the following medicines: a seizure medicine (such as carbamazepine, oxcarbazepine, phenobarbital, phenytoin, Dilantin®, Tegretol®, or Trileptal®), medicine to treat tuberculosis (such as rifabutin, rifampin, rifapentine, Mycobutin®, Priftin®, Rifadin®, or Rimactane®), certain stomach medicines (such as esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole, Aciphex®, Nexium®, Prevacid®, Prilosec®, or Protonix®), dexamethasone (Decadron®), or St. John's wort.


Tell your doctor right away if you start to feel depressed and have thoughts about hurting yourself. Report any unusual thoughts or behaviors that trouble you, especially if they are new or get worse quickly.


rilpivirine may cause you to have extra body fat. Tell your doctor if you notice changes in your body shape, such as an increased amount of fat in the upper back and neck, or around the chest and stomach area. You might also lose fat from your legs, arms, or face.


When you start taking HIV medicines, your immune system may get stronger. If you already have pneumonia or tuberculosis, you may notice new symptoms when your body tries to fight the infections. If this occurs, be sure to tell your doctor.


Make sure any doctor or dentist who treats you knows that you are using rilpivirine. rilpivirine may affect the results of certain medical tests.


rilpivirine will not keep you from giving HIV to your partner during sex. Make sure you understand this and practice safe sex, even if your partner also has HIV, by using a latex condom or other barrier method. rilpivirine will also not keep you from giving HIV to other people if they are exposed to your blood. Do not re-use or share needles with anyone.


Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.


rilpivirine Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


Less common
  • Abdominal or stomach fullness

  • changes in behavior

  • cloudy or bloody urine

  • discouragement

  • feeling sad or empty

  • gaseous abdominal or stomach pain

  • high blood pressure

  • indigestion

  • irritability

  • lack of appetite

  • loss of interest or pleasure

  • recurrent fever

  • severe nausea or vomiting

  • sleeplessness

  • swelling of the face, feet, or lower legs

  • thoughts of killing oneself

  • tiredness

  • trouble concentrating

  • trouble sleeping

  • unable to sleep

  • yellow eyes or skin

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Less common
  • Abdominal or stomach discomfort

  • abnormal dreams

  • decreased appetite

  • diarrhea

  • dizziness

  • fear or nervousness

  • headache

  • nausea

  • rash

  • sleepiness or unusual drowsiness

  • unusual tiredness or weakness

  • vomiting

Incidence not known
  • Decreased amount of fat from your legs, arms, or face

  • increased amount of fat in the upper back and neck, or around the chest and stomach area

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: rilpivirine side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More rilpivirine resources


  • Rilpivirine Side Effects (in more detail)
  • Rilpivirine Dosage
  • Rilpivirine Use in Pregnancy & Breastfeeding
  • Rilpivirine Drug Interactions
  • Rilpivirine Support Group
  • 0 Reviews for Rilpivirine - Add your own review/rating


  • Rilpivirine MedFacts Consumer Leaflet (Wolters Kluwer)

  • Edurant Prescribing Information (FDA)

  • Edurant Consumer Overview



Compare rilpivirine with other medications


  • HIV Infection

Saturday 5 September 2009

Movergan




Movergan may be available in the countries listed below.


Ingredient matches for Movergan



Selegiline

Selegiline hydrochloride (a derivative of Selegiline) is reported as an ingredient of Movergan in the following countries:


  • Germany

International Drug Name Search

Friday 4 September 2009

Hypurin Porcine 30 / 70 Mix




Hypurin Porcine 30/70 Mix may be available in the countries listed below.


UK matches:

  • Hypurin Porcine 30/70 Mix Cartridges (SPC)
  • Hypurin Porcine 30/70 Mix Vials (SPC)

Ingredient matches for Hypurin Porcine 30/70 Mix



Insulin Injection, Biphasic Isophane

Insulin Injection, Biphasic Isophane porcine (a derivative of Insulin Injection, Biphasic Isophane) is reported as an ingredient of Hypurin Porcine 30/70 Mix in the following countries:


  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday 2 September 2009

Benzoyl Peroxide/Hydrocortisone Lotion


Pronunciation: BEN-zoe-il per-OX-ide/hye-droe-KOR-ti-sone
Generic Name: Benzoyl Peroxide/Hydrocortisone
Brand Name: Vanoxide-HC


Benzoyl Peroxide/Hydrocortisone Lotion is used for:

Treating acne and oily skin.


Benzoyl Peroxide/Hydrocortisone Lotion is a kit containing an antibacterial/keratolytic agent and corticosteroid combination along with a cleanser. The effectiveness of benzoyl peroxide appears to be because of its antibacterial, peeling (keratolytic), and drying actions. The corticosteroid reduces inflammation in a way that is not fully understood.


Do NOT use Benzoyl Peroxide/Hydrocortisone Lotion if:


  • you are allergic to any ingredient in Benzoyl Peroxide/Hydrocortisone Lotion

  • you have a viral skin disease (eg, chickenpox, shingles)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Benzoyl Peroxide/Hydrocortisone Lotion:


Some medical conditions may interact with Benzoyl Peroxide/Hydrocortisone Lotion. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have any kind of skin infection, cuts, scrapes, or lessened blood flow to your skin

  • if you have had a recent vaccination, have measles or tuberculosis (TB), or have had a positive TB test

  • if you are taking prednisone or similar medicines

Some MEDICINES MAY INTERACT with Benzoyl Peroxide/Hydrocortisone Lotion. However, no specific interactions with Benzoyl Peroxide/Hydrocortisone Lotion are known at this time.


Ask your health care provider if Benzoyl Peroxide/Hydrocortisone Lotion may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Benzoyl Peroxide/Hydrocortisone Lotion:


Use Benzoyl Peroxide/Hydrocortisone Lotion as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Before applying Benzoyl Peroxide/Hydrocortisone Lotion to the affected area, cleanse the skin with the cleansing lotion. Apply the cleanser to the skin and gently rub. The excess may be removed with a soft cloth or allowed to stay on the skin. When using with water, apply to the skin, moisten with warm water, and gently rub. Rinse with warm water and pat dry.

  • Shake Benzoyl Peroxide/Hydrocortisone Lotion well before each use.

  • Apply a thin film of medicine to the affected area. Gently rub the medicine in until it is evenly distributed.

  • Wash your hands after using Benzoyl Peroxide/Hydrocortisone Lotion.

  • If you miss a dose of Benzoyl Peroxide/Hydrocortisone Lotion, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Benzoyl Peroxide/Hydrocortisone Lotion.



Important safety information:


  • Benzoyl Peroxide/Hydrocortisone Lotion is for external use only. Avoid contact with the eyes, nose, mouth, and other mucous membranes. If you get Benzoyl Peroxide/Hydrocortisone Lotion in your eyes, rinse them right away with cool tap water.

  • Avoid applying Benzoyl Peroxide/Hydrocortisone Lotion to raw or irritated skin, including sunburns, or to open wounds.

  • Several weeks may pass before you see improvement in your acne. Continue to use Benzoyl Peroxide/Hydrocortisone Lotion for the full time recommended by your doctor. If your acne does not improve or if it gets worse, check with your doctor.

  • Talk with your doctor before you use any other medicines, special cleansers, aftershave, or cosmetics on your skin.

  • Benzoyl Peroxide/Hydrocortisone Lotion may cause you to become sunburned more easily. Avoid the sun, sunlamps, or tanning booths until you know how you react to Benzoyl Peroxide/Hydrocortisone Lotion. Use a sunscreen or wear protective clothing if you must be outside for more than a short time.

  • Benzoyl Peroxide/Hydrocortisone Lotion may cause bleaching. Avoid contact with hair, fabrics, or carpeting.

  • Benzoyl Peroxide/Hydrocortisone Lotion should be used with extreme caution in CHILDREN younger than 12 years; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Benzoyl Peroxide/Hydrocortisone Lotion while you are pregnant. It is not known if Benzoyl Peroxide/Hydrocortisone Lotion is found in breast milk. If you are or will be breast-feeding while you use Benzoyl Peroxide/Hydrocortisone Lotion, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Benzoyl Peroxide/Hydrocortisone Lotion:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Dryness; mild irritation or stinging.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; dizziness; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); acne-like rash; burning, cracking, or itching of the skin; excessive hair growth; extreme dryness; inflamed hair follicles; inflammation around the mouth; irritation, redness, peeling, or tenderness not present before you began using Benzoyl Peroxide/Hydrocortisone Lotion; swelling; thinning, softening, or discoloration of the skin.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Benzoyl Peroxide/Hydrocortisone side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include excessive scaling; redness; swelling.


Proper storage of Benzoyl Peroxide/Hydrocortisone Lotion:

Store Benzoyl Peroxide/Hydrocortisone Lotion at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store in a tightly closed container. Throw away any unused medicine after 3 months. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Benzoyl Peroxide/Hydrocortisone Lotion out of the reach of children and away from pets.


General information:


  • If you have any questions about Benzoyl Peroxide/Hydrocortisone Lotion, please talk with your doctor, pharmacist, or other health care provider.

  • Benzoyl Peroxide/Hydrocortisone Lotion is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Benzoyl Peroxide/Hydrocortisone Lotion. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Benzoyl Peroxide/Hydrocortisone resources


  • Benzoyl Peroxide/Hydrocortisone Side Effects (in more detail)
  • Benzoyl Peroxide/Hydrocortisone Use in Pregnancy & Breastfeeding
  • Benzoyl Peroxide/Hydrocortisone Drug Interactions
  • Benzoyl Peroxide/Hydrocortisone Support Group
  • 1 Review for Benzoyl Peroxide/Hydrocortisone - Add your own review/rating


Compare Benzoyl Peroxide/Hydrocortisone with other medications


  • Acne
  • Rosacea

Thursday 27 August 2009

Heparoid Leciva




Heparoid Leciva may be available in the countries listed below.


Ingredient matches for Heparoid Leciva



Heparin

Heparin sodium salt (a derivative of Heparin) is reported as an ingredient of Heparoid Leciva in the following countries:


  • Czech Republic

  • Georgia

  • Romania

  • Slovakia

International Drug Name Search

Monocedocard




Monocedocard may be available in the countries listed below.


Ingredient matches for Monocedocard



Isosorbide Mononitrate

Isosorbide Mononitrate is reported as an ingredient of Monocedocard in the following countries:


  • Netherlands

International Drug Name Search

Wednesday 26 August 2009

Hiberna




Hiberna may be available in the countries listed below.


Ingredient matches for Hiberna



Promethazine

Promethazine hydrochloride (a derivative of Promethazine) is reported as an ingredient of Hiberna in the following countries:


  • Japan

International Drug Name Search

Prostin E2




In the US, Prostin E2 (dinoprostone topical) is a member of the drug class uterotonic agents and is used to treat Abortion, Labor Induction and Trophoblastic Disease.

US matches:

  • Prostin E2

UK matches:

  • Prostin E2 Sterile Solution 1 mg/ml Intravenous
  • Prostin E2 Sterile Solution 10 mg/ml Extra-Amniotic
  • Prostin E2 Sterile Solution 10 mg/ml Intravenous
  • Prostin E2 Vaginal Gel 1 mg and 2 mg
  • Prostin E2 Vaginal Tablets
  • Prostin E2 Sterile Solution 10 mg/ml Intravenous (SPC)
  • Prostin E2 Sterile Solution 10mg/ml Extra-Amniotic (SPC)
  • Prostin E2 Sterile Solution 1mg/ml Intravenous (SPC)
  • Prostin E2 Vaginal Tablets (SPC)

Ingredient matches for Prostin E2



Dinoprostone

Dinoprostone is reported as an ingredient of Prostin E2 in the following countries:


  • Australia

  • Austria

  • Belgium

  • Canada

  • Croatia (Hrvatska)

  • Czech Republic

  • Ghana

  • Greece

  • Hong Kong

  • Hungary

  • Ireland

  • Israel

  • Italy

  • Kenya

  • Liberia

  • Luxembourg

  • New Zealand

  • Oman

  • Portugal

  • Romania

  • Serbia

  • Sierra Leone

  • Singapore

  • Slovakia

  • South Africa

  • Switzerland

  • Taiwan

  • Tanzania

  • Thailand

  • Uganda

  • United Kingdom

  • United States

  • Zimbabwe

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday 24 August 2009

Metilrosanilinio Cloruro Ramini




Metilrosanilinio Cloruro Ramini may be available in the countries listed below.


Ingredient matches for Metilrosanilinio Cloruro Ramini



Methylrosanilinium Chloride

Methylrosanilinium Chloride is reported as an ingredient of Metilrosanilinio Cloruro Ramini in the following countries:


  • Italy

International Drug Name Search

Saturday 15 August 2009

Acido Alendronico Generis




Acido Alendronico Generis may be available in the countries listed below.


Ingredient matches for Acido Alendronico Generis



Alendronic Acid

Alendronic Acid is reported as an ingredient of Acido Alendronico Generis in the following countries:


  • Portugal

International Drug Name Search

Monday 10 August 2009

Septisan




Septisan may be available in the countries listed below.


Ingredient matches for Septisan



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Septisan in the following countries:


  • Spain

Triclocarban

Triclocarban is reported as an ingredient of Septisan in the following countries:


  • Tunisia

International Drug Name Search

Lipolac




Lipolac may be available in the countries listed below.


Ingredient matches for Lipolac



Carbomer

Carbomer is reported as an ingredient of Lipolac in the following countries:


  • Spain

International Drug Name Search

Friday 7 August 2009

Postoperative Pain Medications


Drugs associated with Postoperative Pain

The following drugs and medications are in some way related to, or used in the treatment of Postoperative Pain. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:

Mercaptopurina GSK




Mercaptopurina GSK may be available in the countries listed below.


Ingredient matches for Mercaptopurina GSK



Mercaptopurine

Mercaptopurine is reported as an ingredient of Mercaptopurina GSK in the following countries:


  • Spain

International Drug Name Search

Tuesday 4 August 2009

Protear




Protear may be available in the countries listed below.


Ingredient matches for Protear



Povidone

Povidone is reported as an ingredient of Protear in the following countries:


  • Bangladesh

International Drug Name Search

Monday 3 August 2009

Tamsulosine Mylan




Tamsulosine Mylan may be available in the countries listed below.


Ingredient matches for Tamsulosine Mylan



Tamsulosin

Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Tamsulosine Mylan in the following countries:


  • Belgium

International Drug Name Search

Sunday 2 August 2009

Arginine Glutamate




Arginine Glutamate may be available in the countries listed below.


Ingredient matches for Arginine Glutamate



Arginine

Arginine Glutamate (BAN, JAN, USAN) is known as Arginine in the US.

International Drug Name Search

Glossary

BANBritish Approved Name
JANJapanese Accepted Name
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday 1 August 2009

Bellvirax




Bellvirax may be available in the countries listed below.


Ingredient matches for Bellvirax



Acyclovir

Aciclovir is reported as an ingredient of Bellvirax in the following countries:


  • Ireland

International Drug Name Search

Friday 31 July 2009

Unimezin




Unimezin may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Unimezin



Sulfadimidine

Sulfadimidine is reported as an ingredient of Unimezin in the following countries:


  • Italy

International Drug Name Search

Sunday 26 July 2009

Bromatan-DM Suspension


Pronunciation: brome-fen-IR-a-meen/dex-troe-meth-OR-fan/fen-ill-EF-rin
Generic Name: Brompheniramine/Dextromethorphan/Phenylephrine
Brand Name: Neo DM


Bromatan-DM Suspension is used for:

Relieving symptoms of sinus congestion, runny nose, sneezing, and cough due to colds, upper respiratory infections, and allergies. It may also be used for other conditions as determined by your doctor.


Bromatan-DM Suspension is a decongestant, antihistamine, and cough suppressant combination. It works by constricting blood vessels and reducing swelling in the nasal passages, The antihistamine works by blocking the action of histamine, which helps reduce symptoms such as watery eyes and sneezing while the cough suppressant works in the brain to help decrease the cough reflex to reduce a dry cough.


Do NOT use Bromatan-DM Suspension if:


  • you are allergic to any ingredient in Bromatan-DM Suspension

  • you have severe high blood pressure, severe heart blood vessel disease, rapid heartbeat, or severe heart problems

  • you are unable to urinate or are having an asthma attack

  • you take sodium oxybate (GHB) or if you have taken furazolidone or a monoamine oxidase (MAO) inhibitor (eg, phenelzine) within the last 14 days

Contact your doctor or health care provider right away if any of these apply to you.



Before using Bromatan-DM Suspension:


Some medical conditions may interact with Bromatan-DM Suspension. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a fast, slow, or irregular heartbeat

  • if you have a history of adrenal gland problems (eg, adrenal gland tumor); heart problems; high blood pressure; diabetes; heart blood vessel problems; stroke; glaucoma; a blockage of your bladder, stomach, or intestines; ulcers; trouble urinating; an enlarged prostate or other prostate problems; seizures; or an overactive thyroid

  • if you have a history of asthma, chronic cough, lung problems (eg, chronic bronchitis, emphysema), or chronic obstructive pulmonary disease (COPD), or if your cough occurs with large amounts of mucus

Some MEDICINES MAY INTERACT with Bromatan-DM Suspension. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Beta-blockers (eg, propranolol), catechol-O-methyltransferase (COMT) inhibitors (eg, tolcapone), furazolidone, indomethacin, MAO inhibitors (eg, phenelzine), sodium oxybate (GHB), or tricyclic antidepressants (eg, amitriptyline) because side effects of Bromatan-DM Suspension may be increased

  • Digoxin or droxidopa because the risk of irregular heartbeat or heart attack may be increased

  • Bromocriptine or hydantoins (eg, phenytoin) because side effects may be increased by Bromatan-DM Suspension

  • Guanadrel, guanethidine, mecamylamine, methyldopa, or reserpine because effectiveness may be decreased by Bromatan-DM Suspension

This may not be a complete list of all interactions that may occur. Ask your health care provider if Bromatan-DM Suspension may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Bromatan-DM Suspension:


Use Bromatan-DM Suspension as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Bromatan-DM Suspension may be taken with or without food.

  • Shake well before using.

  • Use a measuring device marked for medicine dosing. Ask your pharmacist for help if you are unsure of how to measure your dose.

  • If you miss a dose of Bromatan-DM Suspension, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Bromatan-DM Suspension.



Important safety information:


  • Bromatan-DM Suspension may cause dizziness, drowsiness, or blurred vision. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Bromatan-DM Suspension. Using Bromatan-DM Suspension alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks.

  • Do not take diet or appetite control medicines while you are taking Bromatan-DM Suspension without checking with your doctor.

  • Bromatan-DM Suspension contains brompheniramine, dextromethorphan, and phenylephrine. Before you begin taking any new prescription or nonprescription medicine, read the ingredients to see if it also contains brompheniramine, dextromethorphan, or phenylephrine. If it does or if you are uncertain, contact your doctor or pharmacist.

  • Do NOT exceed the recommended dose or take Bromatan-DM Suspension for longer than prescribed without checking with your doctor.

  • If your symptoms do not improve within 5 to 7 days or if they become worse, check with your doctor.

  • Bromatan-DM Suspension may cause increased sensitivity to the sun. Avoid exposure to the sun, sunlamps, or tanning booths until you know how you react to Bromatan-DM Suspension. Use a sunscreen or protective clothing if you must be outside for a prolonged period.

  • Phenylketonuria patients - Bromatan-DM Suspension contains phenylalanine.

  • If you are scheduled for allergy skin testing, do not take Bromatan-DM Suspension for several days before the test because it may decrease your response to the skin tests.

  • Before you have any medical or dental treatments, emergency care, or surgery, tell the doctor or dentist that you are using Bromatan-DM Suspension.

  • Use Bromatan-DM Suspension with caution in the ELDERLY because they may be more sensitive to its effects.

  • Caution is advised when using Bromatan-DM Suspension in CHILDREN because they may be more sensitive to its effects.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant while taking Bromatan-DM Suspension, discuss with your doctor the benefits and risks of using Bromatan-DM Suspension during pregnancy. It is unknown if Bromatan-DM Suspension is excreted in breast milk. Do not breast-feed while taking Bromatan-DM Suspension.


Possible side effects of Bromatan-DM Suspension:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Constipation; diarrhea; dizziness; drowsiness; excitability; headache; loss of appetite; nausea; nervousness or anxiety; trouble sleeping; upset stomach; vomiting; weakness.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); difficulty urinating or inability to urinate; fast or irregular heartbeat; hallucinations; seizures; severe dizziness, lightheadedness, or headache; tremor; trouble sleeping; vision changes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Bromatan-DM side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; unusually fast, slow, or irregular heartbeat; vomiting.


Proper storage of Bromatan-DM Suspension:

Store Bromatan-DM Suspension at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Bromatan-DM Suspension out of the reach of children and away from pets.


General information:


  • If you have any questions about Bromatan-DM Suspension, please talk with your doctor, pharmacist, or other health care provider.

  • Bromatan-DM Suspension is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Bromatan-DM Suspension. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Bromatan-DM resources


  • Bromatan-DM Side Effects (in more detail)
  • Bromatan-DM Use in Pregnancy & Breastfeeding
  • Bromatan-DM Drug Interactions
  • Bromatan-DM Support Group
  • 0 Reviews for Bromatan-DM - Add your own review/rating


Compare Bromatan-DM with other medications


  • Cough and Nasal Congestion